ARCHIVES

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

This article is from The Cancer Letter archive.

Vol. 07 No. 33 | August 14, 1981

Download PDF Visit The Full Archive

Related Articles

Program Announcement: Breast Cancer Research

May 28, 1993

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

Cancer “Report Card”: Growing Population Of Cancer Survivors Creates Need For New Research Emphasis, NCI Director Says

March 20, 1998

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

In Brief: Subcommittee Adds $16-18 Million o NVI Budget; Upton Might Leave If Bill Fails

May 25, 1979